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Human Research Program Risk: Impaired control of spacecraft 
associated systems and decreased mobility due to 
vestibular/sensorimotor alterations associated with spaceflight.  
Orion vehicle re-entry will likely produce large cross-coupled angular 
accelerations that may significantly impact crew including their ability to 
operate the vehicle and egress.  
 
Question: Can crewmember spatiomotor abilities be accurately 
predicted and countermeasures and training techniques developed to 
mitigate spatial disorientation during spaceflight?  
 
Countermeasure: Autogenic-Feedback Training Exercise (AFTE) 
 
 
BACKGROUND 
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Autogenic-Feedback Training Exercise: AFTE 
Spaceflight research 
Originally a countermeasure for space motion sickness aboard the Space 
Shuttle, AFTE was also tested as a treatment for post-flight orthostatic 
intolerance on the Russian MIR space station. 
 
 
Ground based research 
• reduces or eliminates Earth-based motion sickness (N=500).  
• improves pilot performance under emergency conditions. 
• relieves nausea and syncope in dysautonomia patients. 
• effective control of blood pressure (increases). 
A 6-hour training method used to teach voluntary control of physiological 
responses and normalize autonomic balance. Patented by NASA in 1997. 
Subjects learn to voluntarily increase and decrease levels of 24 responses. 
BACKGROUND 
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• To simulate the Orion re-entry cross-coupled angular 
accelerations with participants in a rotating chair;  
• To measure physiological responses, manual task performance, 
and motion sickness symptoms; 
• To evaluate the effects of AFTE for mitigating symptoms and 
performance degradation; 
• To determine the minimum amount of training needed to achieve 
these goals.  
 
 
 
 
 
 
 
 
SPECIFIC OBJECTIVES 
 
 
Slide No. 5 
Human Research Program 
B. Toscano 
 
Participants: Twenty men and women volunteers, ages 24 to 65 
 
Groups: AFTE and No Treatment Control (10 per group). Groups 
matched for motion sickness susceptibility and gender 
 
Procedures:  
• standard rotating chair test to assess Motion Sickness susceptibility 
• training on manual task – three, 30 minute sessions  
• modified rotating chair test with manual task – four tests, 1 per week 
• AFTE training – twelve, 30 minute sessions, 4 per week 
 
 
 
 
METHODS 
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Autogenic-Clinical Work Stations 
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Autogenic-Feedback Training Exercise 
(AFTE) Detailed Screen Display 
Skin Conductance, Respiration & Heart Rate 
Blood Volume Pulse both ands and feet 
Skin Temperature both hands and feet 
Muscle activity both arms and legs 
Systolic, Diastolic & MAP Blood 
Pressure Z0=Thoracic Impedance 
Stroke volume, cardiac output, total 
peripheral resistance, DzDt 
Left Ventricular Ejection Time (LVET), 
Respiration volume-chest and abdomen 
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Standard Rotating Chair Test 
(motion sickness susceptibility)  
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Modified Rotating Chair Test  
(simulated spacecraft re-entry) 
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Model of Re-entry Acceleration Rate 
Drogue 
Deploy 
Main Deploy 
Splashdown 
2 rad/s2 
-2 rad/s2 
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Modified Rotating Chair Test 
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Seat Egress and Walk 
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Results - Motion Sickness Tolerance 
Treatment	 Gender		 Age:	mean	(se)	 Rotations	Tolerated:	mean	(se)	
AFTE	 3f,	7m	 35.9	(3.7)	 170.6	(39.8)	
CONTROL	 3f,	7m	 35.2	(3.2)	 176	(45.3)	
	
Group Demographics 
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Results - Motion Sickness Symptoms  
 
 Groups 
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AFTE Control
Test 2 = 2 hours of AFTE, p<0.05 
Test 3 = 4 hours of AFTE, p<0.04 
Test 4 = 6 hours of AFTE, p<0.01 
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X35 Training Data 
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Elapsed Time 
Skin Conductance   
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Elapsed Time 
Systolic Blood Pressure 
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X28 Heart Rate Data before AFTE and 
following 2 hours of AFTE 
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Baseline Resting Baseline - Task 
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20 rpm 
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5 rpm stop 
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& walk 
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Results – Physiological Measures 
 
AFTE Subject  28 (moderate susceptible) 
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Conclusions 
Objectives of this study were successfully met 
 
• Simulated Orion Test did induce motion sickness symptoms 
 
• AFTE subjects had significantly lower symptoms than Control Subjects 
 
• Two hours of AFTE was sufficient for controlling symptoms  
 
• Additional practice improved  subjects’ ability to self-regulate their responses 
 
• Proposed analog studies will include 2 hours of AFTE pre-mission, and will 
provide wearable biosensors /mobile displays to allow self-practice during 
the mission  
 
• Self-reports and performance tests during analog studies will allow  more 
detailed assessment of AFTE effects during long duration missions. 
